Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential

Toxicology

Volumn 313, Issue 1, 2013, Pages 15-23

  Winkler, David A ^a,b   Mombelli, Enrico ^c   Pietroiusti, Antonio ^d   Tran, Lang ^e   Worth, Andrew ^f   Fadeel, Bengt ^g   McCall, Maxine J ^a  

^a CSIRO   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

^f JOINT RESEARCH CENTRE   (Italy)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chemical category; Computational toxicology; Nanotoxicology; QSAR; Regulation

Indexed keywords

NANOMATERIAL;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; BIOAVAILABILITY; CONCENTRATION (PARAMETERS); COST; ECOSYSTEM RESTORATION; ECOTOXICITY; ELECTROPHILICITY; ENVIRONMENTAL CHANGE; ENVIRONMENTAL IMPACT; FLUORESCENCE CORRELATION SPECTROSCOPY; FOLLOW UP; GENE REGULATORY NETWORK; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; NANOTOXICOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; RISK ASSESSMENT; SOLUBILITY; SURFACE PLASMON RESONANCE; SURFACE PROPERTY; WATER HARDNESS; ZETA POTENTIAL;

CHEMICAL CATEGORY; COMPUTATIONAL TOXICOLOGY; NANOTOXICOLOGY; QSAR; REGULATION;

ANIMALS; BIOMEDICAL RESEARCH; COMPUTER SIMULATION; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; NANOPARTICLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TOXICOLOGY;

ANIMALIA;

EID: 84885757504     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.11.005     Document Type: Article

References (79)

1. Barnard A.S. How can ab initio simulations address risks in nanotech?. Nat. Nanotechnol. 2009, 4:332-335.
2. Bassan A., Worth A.P. Computational tools for regulatory needs. Computational Toxicology, Risk Assessment for Pharmaceutical and Environmental Chemicals 2007, 751-775. John Wiley & Sons, Hoboken, NJ. S. Ekins (Ed.).
3. Batley G.E., Kirby J.K., McLaughlin M.J. Fate and risks of nanomaterials in aquatic and terrestrial environments. Acc. Chem. Res. 2012, 10.1021/ar2003368.
4. Burden F.R., Winkler D.A. Robust QSAR models using Bayesian regularized neural networks. J. Med. Chem. 1999, 42:3183-3187.
5. Burello E., Worth A.P. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 2011, 5:228-235.
6. Cattaneo A.G., Gornati R., Sabbioni E., Chiriva-Internati M., Cobos E., Jenkins M.R., Bernardini G. Nanotechnology and human health: risks and benefits. J. Appl. Toxicol. 2010, 30:730-744.
7. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., Bawendi M.G., Semmler-Behnke M., Frangioni J.V., Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 2010, 28:1300-1303.
8. Clark K.A., White R.H., Silbergeld E.K. Predictive models for nanotoxicology: current challenges and future opportunities. Regul. Toxicol. Pharmacol. 2011, 59:361-363.
9. Collins F.S., Gray G.M., Bucher J.R. Toxicology. Transforming environmental health protection. Science 2008, 5:906-907.
10. Damoiseaux R., George S., Li M., Pokhrel S., Ji Z., France T., Suarez E., Rallo R., Mädler L., Cohen Y., Hoek E.M.V., Nel A. No time to lose-high throughput screening to assess nanomaterial safety. Nanoscale 2011, 3:1345-1360.
11. Dell'Orco D., Lundqvist M., Oslakovic C., Cedervall T., Linse S. Modelling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS ONE 2010, 5:e10949.
12. Detriche S., Zorzini G., Colomer J.F., Fonseca A., Nagy J.B. Application of the Hansen solubility parameters theory to carbon nanotubes. J. Nanosci. Nanotechnol. 2008, 8:6082-6092.
13. Diderich R. Tools for category formation and read-across: overview of the OECD (Q)SAR Toolbox. In Silico Toxicology: Principles and Applications 2010, The Royal Society of Chemistry, Cambridge, UK, pp. 385-407.
14. Epa V.C., Winkler D.A., Tran L. Adverse Effects of Engineered Nanoparticles 2012, Academic Press, London. Fadeel, Pietroiusti, Shvedova (Eds.).
15. Epa V.C., Burden F.R., Tassa C., Weissleder R., Shaw S., Winkler D.A. Modelling biological activities of nanoparticles. Nano Lett. 2012, 12:5808-5812.
16. Feliu N., Fadeel B. Nanotoxicology: no small matter. Nanoscale 2010, 2:2514-2520.
17. Feris K., Otto C., Tinker J., Wingett D., Punnoose A., Thurber A., Kongara M., Sabetian M., Quinn B., Hanna C., Pink D. Electrostatic interactions affect nanoparticle-mediated toxicity to gram-negative bacterium Pseudomonas aeruginosa PAO1. Langmuir 2010, 26:4429-4436.
18. Fubini B., Ghiazza M., Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 2010, 4:347-363.
19. Fourches D., Pu D., Tassa C., Weissleder R., Shaw S.Y., Mumper R.J., Tropsha A. Quantitative nanostructure-activity relationship modelling. ACS Nano 2010, 4:5703-5712.
20. Fourches D., Pu D., Tropsha A. Exploring quantitative nanostructure-activity relationships (QNAR) modelling as a tool for predicting biological effects of manufactured nanoparticles. Comb. Chem. High Throughput Screen. 2011, 14:217-225.
21. Gaster R.S., Xu L., Han S., Wilson R.J., Hall D.A., Osterfeld H.Y., Wang S.X. Quantification of protein interactions and solution transport using high-density GMR sensor arrays. Nat. Nanotechnol. 2011, 6:314-320.
22. George S., Pokhrel S., Xia T., Gilbert B., Ji Z., Schowalter M., Rosenauer R., Damoiseaux R., Bradley K.A., Mädler L., Nel A.E. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 2010, 4:15-29.
23. George S., Xia T., Rallo R., Zhao Y., Ji Z., Lin S., Wang X., Zhang H., France B., Schoenfeld D., Damoiseaux R., Liu R., Lin S., Bradley K.A., Cohen Y., Nel A.E. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 2011, 5:1805-1817.
24. Handy R.D., Owen R., Valsami-Jones E. The ecotoxicology of nanoparticles and nanomaterials: current status, knowledge gaps, challenges, and future needs. Ecotoxicology 2008, 17:315-325.
25. Hansen C.M. Hansen Solubility Parameters. A user's Handbook 2007, Taylor & Francis Group, Boca Raton. 2nd ed.
26. Hansen S.F., Larsen B.H., Olsen A.B., Baun A. Categorization framework to aid hazard identification of nanomaterials. Nanotoxicology 2007, 1:243-250.
27. Hansen F.S., Maynard A., Baun A., Tickner J.A. Late lessons from early warnings for nanotechnology. Nat. Nanotechnol. 2008, 3:444-447.
28. Hu J.X., Shipley H.J. Evaluation of desorption of Pb (II), Cu (II) and Zn (II) from titanium dioxide nanoparticles. Sci. Total Environ. 2012, 431:209-220.
29. Judson R.S., Houck K.A., Kavlock R.J., Knudsen T.B., Martin M.T., Mortensen H.M., Reif D.M., Rotroff D.M., Shah I., Richard A.M., Dix D.J. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 2010, 118:485-492.
30. Katritzky A.R., Kuanar M., Slavov S., Hall C.D., Karelson M., Kahn I., Dobchev D.A. Quantitative correlation of physical and chemical properties with chemical structure: utility for prediction. Chem. Rev. 2010, 110:5714-5789.
31. Klaine S.J., Alvarez P.J.J., Batley G.E., Fernandes T.F., Handy R.D., Lyo D.Y., Mahendra S., Mclaughlin M.J., Lead J.R. Nanomaterials in the environment: behavior, fate, bioavailability, and effects. Environ. Toxicol. Chem. 2008, 27:1825-1851.
32. Knudsen T.B., Houck K.A., Sipes N.S., Singh A.V., Judson R.S., Martin M.T., Weissman A., Kleinstreuer N.C., Mortensen H.M., Reif D.M., Rabinowitz J.R., Setzer R.W., Richard A.M., Dix D.J., Kavlock R.J. Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. Toxicology 2011, 282:1-15.
33. Kunzmann A., Andersson B., Vogt C., Feliu N., Ye F., Gabrielsson S., Toprak M.S., Buerki-Thurnherr T., Laurent S., Vahter M., Krug H., Muhammed M., Scheynius A., Fadeel B. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol. Appl. Pharmacol. 2011, 253:81-93.
34. Le T.C., Epa V.C., Burden F.R., Winkler D.A. Quantitative structure-property relationship modelling of diverse materials properties. Chem. Rev. 2012, 112:2889-2919.
35. Lee S., Park K., Ahn H.S., Kim D. Importance of structural information in predicting human acute toxicity from in vitro cytotoxicity data. Toxicol. Appl. Pharmacol. 2010, 246:38-48.
36. Lessigiarska I., Worth A.P., Netzeva T.I., Dearden J.C., Cronin M.T. Quantitative structure-activity-activity and quantitative structure-activity investigations of human and rodent toxicity. Chemosphere 2006, 65:1878-1887.
37. Liu J., Hopfinger A.J. Identification of possible sources of nanotoxicity from carbon nanotubes inserted into membrane bilayers using membrane interaction quantitative structure-activity relationship analysis. Chem. Res. Toxicol. 2008, 21:459-466.
38. Liu R., Rallo R., George S., Ji Z., Nair S., Nel A.E., Cohen Y. Classification NanoSAR development for cytotoxicity of metal oxide nanoparticles. Small 2011, 7:1118-1126.
39. Lynch I., Dawson K.A. Protein-nanoparticle interactions. Nano Today 2008, 3:40-47.
40. Matthews E.J., Kruhlak N.L., Cimino M.C., Benz R.D., Contrera J.F. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol. 2006, 44:83-96.
41. Matthews E.J., Kruhlak N.L., Cimino M.C., Benz R.D., Contrera J.F. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Regul. Toxicol. Pharmacol. 2006, 44:97-110.
42. Mombelli E., Ringeissen S. The computational prediction of toxicological effects in regulatory contexts. Current use and future potential of (Q)SAR tools. Actual. Chim. 2009, 335:52-59.
43. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
44. Martin M.T., Dix D.J., Judson R.S., Kavlock R.J., Reif D.M., Richard A.M., Rotroff D.M., Romanov S., Medvedev A., Poltoratskaya N., Gambarian M., Moeser M., Makarov S.S., Houck K.A. Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. Chem. Res. Toxicol. 2010, 23:578-590.
45. Maynard A.D., Warheit D.B., Philbert M.A. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol. Sci. 2011, 120:S109-S129.
46. Monteiller C., Tran L., MacNee W., Faux S., Jones A., Miller B., Donaldson K. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 2007, 64:609-615.
47. Morris J., Willis J., De Martinis D., Hansen B., Laursen H., Sintes J.R., Kearns P., Gonzalez M. Science policy considerations for responsible nanotechnology decisions. Nat. Nanotechnol. 2011, 6:73-77.
48. Mura S., Hillaireau H., Nicolas J., Le Droumaguet B., Gueutin C., Zanna S., Tsapis N., Fattal E. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int. J. Nanomed. 2011, 6:2591-2605.
49. Nantasenamat C., Isarankura-Na-Ayudhya C., Prachayasittikul V. Advances in computational methods to predict the biological activity of compounds. Expert Opin. Drug Discov. 2010, 5:633-654.
50. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:8.
51. Osmond-McLeod M.J., Poland C.A., Murphy F., Waddington L., Morris H., Hawkins S.C., Clark S., Aitken R., McCall M.J., Donaldson K. Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part. Fibre Toxicol. 2011, 13:8-15.
52. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., Schmid G., Brandau W., Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
53. Park M.V., Lankveld D.P., van Loveren H., de Jong W.H. The status of in vitro toxicity studies in the risk assessment of nanomaterials. Nanomedicine 2009, 4:669-685.
54. Peng X., Palma S., Fisher N.S., Wong S.S. Effect of morphology of ZnO nanostructures on their toxicity to marine algae. Aquat. Toxicol. 2011, 102:186-196.
55. Péry A.R.R., Brochot C., Hoet P.H.M., Nemmar A., Bois F.Y. Development of a physiologically based kinetic model for 99m-Technetium-labelled carbon nanoparticles inhaled by humans. Inhal. Toxicol. 2009, 21:1099-1107.
56. Pietroiusti A., Massimiani M., Fenoglio I., Colonna M., Valentini F., Palleschi G., Camaioni A., Magrini A., Siracusa G., Bergamaschi A., Sgambato A., Campagnolo L. Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. ACS Nano 2011, 5:4624-4633.
57. Poater A., Gallegos Saliner A., Solà M., Cavallo L., Worth A.P. Computational methods to predict the reactivity of nanoparticles through structure-property relationships. Expert Opin. Drug Deliv. 2010, 7:295-305.
58. Pumera M. Nanotoxicology: the molecular science point of view. Chem. Asian J. 2011, 6:340-348.
59. Puzyn T., Leszczynska D., Leszczynski J. Toward the development of "nano-QSARs": advances and challenges. Small 2009, 5:2494-2509.
60. Puzyn T., Rasulev B., Gajewicz A., Hu X., Dasari T.P., Michalkova A., Hwang H.M., Toropov A., Leszczynska D., Leszczynski J. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol. 2011, 6:175-178.
61. Rai M., Yadav A., Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 2009, 27:76-83.
62. Richard A.M., Yang C., Judson R.S. Toxicity data informatics: supporting a new paradigm for toxicity prediction. Toxicol. Mech. Methods 2008, 18:103-118.
63. Rivera Gil P., Oberdörster G., Elder A., Puntes V., Parak W.J. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010, 26:5527-5531.
64. Röcker R., Pötzl M., Zhang F., Parak W.J., Nienhaus G.U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat. Nanotechnol. 2009, 4:577-580.
65. Roh J.Y., Sim S.J., Yi J., Park K., Chung K.H., Ryu D.Y., Choi J. Ecotoxicity of silver nanoparticles on the soil nematode Caenorhabditis elegans using functional ecotoxicogenomics. Environ. Sci. Technol. 2009, 43:3933-3940.
66. Sayes C., Ivanov I. Comparative study of predictive computational models for nanoparticle-induced cytotoxicity. Risk Anal. 2010, 30:1723-1734.
67. Service R.F. Can high-speed tests sort out which nanomaterials are safe?. Science 2008, 321:1036-1037.
68. Shaw S.Y., Westly E.C., Pittet M.J., Subramanian A., Schreiber S.L., Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7387-7392.
69. Shvedova A.A., Kagan V.E., Fadeel B. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu. Rev. Pharmacol. Toxicol. 2010, 50:63-88.
70. Tassa C., Duffner J.L., Lewis T.A., Weissleder R., Schreiber S.L., Koehler A.N., Shaw S.Y. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjugate Chem. 2010, 21:14-19.
71. Tetard L., Passian A., Venmar K.T., Lynch R.M., Voy B.H., Shekhawat G., Dravid V.P., Thundat T. Imaging nanoparticles in cells by nanomechanical holography. Nat. Nanotechnol. 2008, 3:501-505.
72. Toropov A.A., Toropova A.P., Benfenati E., Leszczynska D., Leszczynski J. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations. J. Comput. Chem. 2010, 31:381-392.
73. Wang S., Dormidontova E.E. Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations. Biomacromolecules 2010, 11:1785-1795.
74. Xia X.R., Monteiro-Riviere N.A., Mathur S., Song X., Xiao L., Oldenberg S.J., Fadeel B., Riviere J.E. Mapping the surface adsorption forces of nanomaterials in biological systems. ACS Nano 2011, 5:9074-9081.
75. Xia X.R., Monteiro-Riviere N.A., Riviere J.E. An index for characterization of nanomaterials in biological systems. Nat. Nanotechnol. 2010, 5:671-675.
76. Yang Y., Qu Y., Lü X. Global gene expression analysis of the effects of gold nanoparticles on human dermal fibroblasts. J. Biomed. Nanotechnol. 2010, 6:234-246.
77. Yang Y., Lin T., Weng X.L., Darr J.A., Wang X.Z. Data flow modeling, data mining and QSAR in high throughput discovery of functional nanomaterials. Comput. Chem. Eng. 2011, 35:671-678.
78. Zhang T., Stilwell J.L., Gerion D., Ding L., Elboudwarej O., Cooke P.A., Gray J.W., Alivisatos A.P., Chen F.F. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett. 2006, 6:800-808.
79. Zhou H., Mu Q., Gao N., Liu A., Xing Y., Gao S., Zhang Q., Qu G., Chen Y., Liu G., Zhang B., Yan B. A nanocombinatorial library strategy for the discovery of nanotubes with reduced protein binding, cytotoxicity, and immune response. Nano Lett. 2008, 8:859-865.